EBUS/Spectrum Analysis

N/ACompletedNCT01972386

University Health Network, Toronto122 enrolled

Overview

To evaluate the clinical benefit of spectrum analysis of endobronchial ultrasound images of lymph nodes during EBUS TBNA for lymph node staging in patients with lung cancer.

Study Type

OBSERVATIONAL

Enrollment

122

Conditions

Lung Cancer

Interventions

Spectrum Image Analysis using a Linear Array Ultrasound BronchoscopeDEVICE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Ages 18 years or older * Patients with known or suspected lung cancer who require EBUS-TBNA for lymph node staging Exclusion Criteria: * Patients who are deemed on clinical grounds not to be medically fit for a bronchoscopy * Inability to give informed consent * Patients who are pregnant

Locations (1)

University Health Network

Toronto, Ontario, Canada

Outcomes

Primary Outcomes

Lymph Node Staging

The lymph node staging will be determined by the pathology report of the biopsy taken from the patients lymph node(s).

Time frame: Pathology report will be completed as soon as possible after the procedure. (Within one year)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.